How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Robotic-Assisted Laparoscopic Surgery Market
- By Surgery Type: Urologic Surgery, Gynecologic Surgery, General Surgery, Cardiothoracic Surgery, Colorectal Surgery, Head and Neck Surgery
- By Component: Robotic Surgical Systems, Instruments and Accessories, Imaging Systems, Software and Services
- By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
- By Application: Prostatectomy, Hysterectomy, Cholecystectomy, Nephrectomy, Colorectal Resection
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Urologic Surgery leads By Surgery Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.166 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.174 →
Full report · locked preview
Everything inside the Robotic-Assisted Laparoscopic Surgery Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Surgery Type 6
Component 4
End User 3
Application 5
Companies profiled
Intuitive Surgical Inc.
Medtronic plc
Stryker Corporation
Smith & Nephew plc
TransEnterix
Inc. (Asensus Surgical)
Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)
CMR Surgical Ltd.
Titan Medical Inc.
Renishaw plc
Hansen Medical Inc.
Medrobotics Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Intuitive Surgical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Smith & Nephew plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →TransEnterix
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Inc. (Asensus Surgical)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →CMR Surgical Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Titan Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Renishaw plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Hansen Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Medrobotics Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Avatera Medical GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Distalmotion SA
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Senhance Surgical (Asensus Surgical)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,679M by 2033 · 5.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Urologic Surgery33.2
- Gynecologic Surgery15.7
- General Surgery10.0
- Cardiothoracic Surgery10.9
- Colorectal Surgery18.3
- Head and Neck Surgery11.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,406M → $2,044M · 4.8%
Europe$979.7M → $1,448M · 5.0%
Asia Pacific$894.5M → $1,561M · 7.2%
Latin America$553.7M → $871.5M · 5.8%
Middle East and Africa$426.0M → $653.1M · 5.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.732026
5.752027
5.762028
5.772029
5.792030
5.802031
5.812032
5.812033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Intuitive Surgical Inc.11.4
- Medtronic plc22.9
- Stryker Corporation10.8
- Smith & Nephew plc5.2
- TransEnterix11.9
- Inc. (Asensus Surgical)9.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Surgery Type13.7%
Component15.3%
End User33.7%
Application37.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.1
- Europe22.0
- Asia Pacific23.7
- Latin America13.2
- Middle East and Africa9.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Intuitive Surgical Inc. | 84 | 90 | 88 | 85 | 74 | 81 | 84 |
| Medtronic plc | 81 | 86 | 70 | 71 | 79 | 93 | 80 |
| Stryker Corporation | 77 | 87 | 69 | 70 | 81 | 83 | 78 |
| Smith & Nephew plc | 63 | 67 | 70 | 78 | 79 | 57 | 69 |
| TransEnterix | 77 | 69 | 76 | 63 | 71 | 59 | 69 |
| Inc. (Asensus Surgical) | 52 | 55 | 61 | 59 | 68 | 51 | 58 |
| Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson) | 64 | 45 | 64 | 45 | 48 | 52 | 53 |
| CMR Surgical Ltd. | 60 | 47 | 54 | 57 | 50 | 38 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Intuitive Surgical Inc.
- Medtronic plc
- Stryker Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc. | ✓ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Medtronic plc | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Stryker Corporation | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Smith & Nephew plc | ◐ | ✓ | ✓ | ✓ | ✓ | − |
| TransEnterix | ✓ | ◐ | ✓ | − | ◐ | − |
| Inc. (Asensus Surgical) | ◐ | ◐ | ◐ | − | ◐ | − |
| Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson) | − | ◐ | ◐ | − | − | − |
| CMR Surgical Ltd. | ◐ | − | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Intuitive Surgical Inc.84
2Medtronic plc80
3Stryker Corporation78
4Smith & Nephew plc69
5TransEnterix69
6Inc. (Asensus Surgical)58
7Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)53
8CMR Surgical Ltd.51
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Intuitive Surgical Inc.Medtronic plcStryker Corporation
Challenger2
Strong scale, closing on the leaders.
Smith & Nephew plcTransEnterix
Contender1
Focused players with pockets of strength.
Inc. (Asensus Surgical)
Niche2
Specialists in a single segment or region.
Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)CMR Surgical Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Surgery Type in North America, then scale across Robotic-Assisted Laparoscopic Surgery Market — a $112M beachhead inside a $1.97B market.
Beachhead (SOM)$112Mobtainable near-term
Serviceable (SAM)$705Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Urologic Surgery
Best fit — highest urgency & budget in Surgery Type.
Economic buyer77 fit
Gynecologic Surgery
Strong fit — clear ROI and a fast path to value.
End user66 fit
General Surgery
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Surgery Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Component & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel29%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Surgery Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Robotic-Assisted Laparoscopic Surgery Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified22%
Evaluation14%
Closed-won7%
$20.6KCAC
$112KLTV
5.4:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Robotic-Assisted Laparoscopic Surgery Market is a resilient opportunity — $5.09B by 2033, compounding at 5.1%.
TAM · 2025$3.41Btoday
TAM · 2033$5.09Bforecast
CAGR5.1%2027–2033
Cumulative$37.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.09BTotal addressable market
SAM$1.75BServiceable available market
SOM$346MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.1% CAGR
Demand compounds through 2033, outpacing GDP across Surgery Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Surgery Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.09BLarge & growingTAM by 2033 at 5.1% CAGR
$1.75BServiceable nowreachable with today’s model
$346MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.97BBear3.3% CAGR
$5.09BBase5.1% CAGR
$6.51BBull6.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Component optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Robotic-Assisted Laparoscopic Surgery Market — a $1.52B market by 2033. Plan: grow share from 10.3% to 18.0%.
Market size · 2033$1.52Btotal addressable
Market CAGR3.6%2027–2033
Target share18.0%from 10.3% today
Revenue ambition$274Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.3% | 18.0% | On track |
| Revenue | $152M | $274M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 33.5% | 44.4% | Ahead |
| Customer retention | 85.8% | 96.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Surgery Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Component capability
A defensible second engine — invest in Component to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Surgery Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Component
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $29M capacity & capability investment
- Greenlight bolt-on M&A in Component
- Authorise North America expansion plan
- Fund R&D program for Surgery Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Robotic-Assisted Laparoscopic Surgery Market conversation — a $5.54B market you can size, segment and defend in minutes.
Market size · 2033$5.54Btotal opportunity
Growth8.5%CAGR to 2033
Addressable buyers1,695+accounts in scope
Typical ROI4.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Surgery Type
Goal Grow share in Surgery Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.6×return on cost, year one
< 4 mopayback period
$49K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Intuitive Surgical Inc.Medtronic plcStryker CorporationSmith & Nephew plcTransEnterixInc. (Asensus Surgical)Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)CMR Surgical Ltd.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Robotic-Assisted Laparoscopic Surgery Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Robotic-Assisted Laparoscopic Surgery Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Robotic-Assisted Imaging Technologies Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportRobotic-Assisted Hip Replacement Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportRobotic Assisted Gait Trainer Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportRobotic-assisted Bronchoscopy Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportRobotic Aseptic Filling Machines Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportRobotic Arms in Laboratories Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportRoboticare Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportRobotic and Navigation (RN) Systems in Orthopaedic Surgery Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportRobot Endoscope Equipment Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportRobot Care Systems(RCS) Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportRobenidine Hydrochloride Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportRNS System Market
Market size, share, segmentation and regional forecast.
$326M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.